摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1-(4-bromophenyl)-3-(5-chloro-2-hydroxyphenyl)prop-2-en-1-one | 1258952-00-9

中文名称
——
中文别名
——
英文名称
1-(4-bromophenyl)-3-(5-chloro-2-hydroxyphenyl)prop-2-en-1-one
英文别名
——
1-(4-bromophenyl)-3-(5-chloro-2-hydroxyphenyl)prop-2-en-1-one化学式
CAS
1258952-00-9
化学式
C15H10BrClO2
mdl
——
分子量
337.6
InChiKey
HWRQKFLAGDDJGS-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    4.7
  • 重原子数:
    19.0
  • 可旋转键数:
    3.0
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.0
  • 拓扑面积:
    37.3
  • 氢给体数:
    1.0
  • 氢受体数:
    2.0

反应信息

  • 作为反应物:
    描述:
    参考文献:
    名称:
    Synthesis, biological evaluation of novel 4,5-dihydro-2H-pyrazole 2-hydroxyphenyl derivatives as BRAF inhibitors
    摘要:
    A series of novel 4,5-dihydropyrazole derivatives (3a-3t) containing hydroxyphenyl moiety as potential V600E mutant BRAF kinase (BRAF(V600E)) inhibitors were designed and synthesized. Docking simulation was performed to insert compounds 3d (1-(5-(5-chloro-2-hydroxyphenyl)-3-(p-tolyl)-4,5-dihydro-1H-pyrazol-1-yl)ethanone) and 3m (1-(3-(4-chlorophenyl)-5-(3,5-dibromo-2-hydroxyphenyl)-4,5-dihydro-1H-pyrazol-1-yl)ethanone) into the crystal structure of BRAF(V600E) to determine the probable binding model, respectively. Based on the preliminary results, compound 3d and 3m with potent inhibitory activity in tumor growth may be a potential anticancer agent. Results of the bioassays against BRAF(V600E), MCF-7 human breast cancer cell line and WM266.4 human melanoma cell line all showed several compounds had potent activities IC50 value in low micromolar range, among them, compound 3d and compound 3m showed strong potent anticancer activity, which were proved by that 3d: IC50 = 1.31 mu M for MCF-7 and IC50 = 0.45 mu M for WM266.5, IC50 = 0.22 mu M for BRAF(V600E), 3m: IC50 = 0.97 mu M for MCF-7 and IC50 = 0.72 mu M for WM266.5, IC50 = 0.46 mu M for BRAF(V600E), which were comparable with the positive control Erlotinib. (C) 2012 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmc.2012.08.020
  • 作为产物:
    描述:
    4-溴苯乙酮5-氯代水杨醛 在 sodium hydroxide 作用下, 以 乙醇 为溶剂, 生成 1-(4-bromophenyl)-3-(5-chloro-2-hydroxyphenyl)prop-2-en-1-one
    参考文献:
    名称:
    Synthesis, biological evaluation of novel 4,5-dihydro-2H-pyrazole 2-hydroxyphenyl derivatives as BRAF inhibitors
    摘要:
    A series of novel 4,5-dihydropyrazole derivatives (3a-3t) containing hydroxyphenyl moiety as potential V600E mutant BRAF kinase (BRAF(V600E)) inhibitors were designed and synthesized. Docking simulation was performed to insert compounds 3d (1-(5-(5-chloro-2-hydroxyphenyl)-3-(p-tolyl)-4,5-dihydro-1H-pyrazol-1-yl)ethanone) and 3m (1-(3-(4-chlorophenyl)-5-(3,5-dibromo-2-hydroxyphenyl)-4,5-dihydro-1H-pyrazol-1-yl)ethanone) into the crystal structure of BRAF(V600E) to determine the probable binding model, respectively. Based on the preliminary results, compound 3d and 3m with potent inhibitory activity in tumor growth may be a potential anticancer agent. Results of the bioassays against BRAF(V600E), MCF-7 human breast cancer cell line and WM266.4 human melanoma cell line all showed several compounds had potent activities IC50 value in low micromolar range, among them, compound 3d and compound 3m showed strong potent anticancer activity, which were proved by that 3d: IC50 = 1.31 mu M for MCF-7 and IC50 = 0.45 mu M for WM266.5, IC50 = 0.22 mu M for BRAF(V600E), 3m: IC50 = 0.97 mu M for MCF-7 and IC50 = 0.72 mu M for WM266.5, IC50 = 0.46 mu M for BRAF(V600E), which were comparable with the positive control Erlotinib. (C) 2012 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmc.2012.08.020
点击查看最新优质反应信息

文献信息

  • Efficient Method for the Synthesis of Optically Active 2-Amino-2-chromene Derivatives via One-Pot Tandem Reactions
    作者:Jian-Wu Xie、Xiong Huang、Li-Ping Fan、Dong-Cheng Xu、Xin-Sheng Li、Hong Su、Yi-Hang Wen
    DOI:10.1002/adsc.200900579
    日期:2009.12
    The asymmetric synthesis of functionalized 2-amino-2-chromene derivatives with high enantioselectivities via one-pot tandem reactions of functionalized α,β-unsaturated ketones with malononitrile catalyzed by 9-amino-9-deoxyepiquinine (1a) in combination with (R)-1,1′-binaphth-2,2′-diyl hydrogen phosphate (1c) is reported for the first time.
    具有高对映选择性官能化的2-基-2-苯并喃衍生物的不对称合成通过官能化的α,β不饱和酮与丙二腈由9-基-9- deoxyepiquinine(催化的一锅串联反应1A组合地)与([R )首次报道了-1,1'-联萘-2,2'-二氢磷酸氢盐(1c)。
  • 一种手性季碳恶唑啉酮化合物的合成方法
    申请人:苏州大学
    公开号:CN104447604B
    公开(公告)日:2016-08-24
    本发明公开了一种手性季碳恶唑啉酮化合物的合成方法,具体为以邻羟基查尔酮与吖内酯为反应物,在手性多功能手性奎宁硫脲催化下,在溶剂中合成得到产物。本发明公开的方法原料简单易得,反应条件温和,后处理简单方便,适用的底物范围广,收率高,对映选择性高;由此合成得到的产物可用以合成药物和杀虫剂的中间体。
  • 一种手性3,4-二氢香豆素衍生化合物合成方 法
    申请人:苏州大学
    公开号:CN104860911B
    公开(公告)日:2017-03-22
    本发明公开了一种手性3,4‑二氢香豆素衍生化合物的合成方法,具体为以邻羟基查尔酮与吖内酯为反应物,在手性多功能手性奎宁硫脲催化下,在溶剂中合成得到产物。本发明公开的方法原料简单易得,反应条件温和,后处理简单方便,适用的底物范围广,收率高,对映选择性高;由此合成得到的产物可用以合成药物和杀虫剂的中间体。
  • Asymmetric Synthesis of Dihydrocoumarins Containing Contiguous Quaternary and Tertiary Stereogenic Centers Catalyzed by a<i>Cinchona</i>-Alkaloid-Based Bifunctional Thiourea Derivative
    作者:Shao-Yun Zhang、Ming Lv、Shao-Jie Yin、Nai-Kai Li、Jun-Qi Zhang、Xing-Wang Wang
    DOI:10.1002/adsc.201500666
    日期:2016.1.7
    contiguous quaternary and tertiary stereogenic centers has been efficiently constructed via domino asymmetric Michael addition/transesterification reactions of azlactones with o‐hydroxychalcones using a quinine‐derived thiourea as bifunctional organocatalyst. Under mild reaction conditions, the optically active 3,4‐dihydrocoumarins were generally obtained in 63–96% yields with >20:1 dr and 81–96% ee.
    通过奎宁衍生的硫脲作为双功能有机催化剂,通过氮杂内酰胺与邻羟基查尔酮的多米诺不对称迈克尔加成/酯交换反应,已经有效地构建了一系列包含对映体的3,4-二氢香豆素,这些连续的季和叔立体构型中心。在温和的反应条件下,通常以63-96%的产率获得旋光的3,4-二氢香豆素,dr > 20:1 ,ee达到81-96%。
查看更多

同类化合物

(2Z)-1,3-二苯基-2-丙烯-1-酮,2-丙烯-1-酮,1,3-二苯基-,(2Z)- 龙血素D 龙血素A 龙血素 B 黄色当归醇F 黄色当归醇B 黄腐醇; 黄腐酚 黄腐醇 D; 黄腐酚 D 黄腐酚B 黄腐酚 黄腐酚 黄卡瓦胡椒素 C 高紫柳查尔酮 阿普非农 阿司巴汀 阿伏苯宗 金鸡菊查耳酮 邻肉桂酰苯甲酸 达泊西汀杂质25 豆蔻明 补骨脂色烯查耳酮 补骨脂查耳酮 补骨脂呋喃查耳酮 补骨脂乙素 蜡菊亭; 4,2',4'-三羟基-6'-甲氧基查耳酮 苯酚,4-[3-(2-羟基苯基)-1-苯基丙基]-2-(3-苯基丙基)- 苯磺酰胺,N-[4-[3-(3-羟基苯基)-1-羰基-2-丙烯基]苯基]- 苯磺酰胺,N-[3-[3-(4-羟基-3-甲氧苯基)-1-羰基-2-丙烯基]苯基]- 苯磺酰胺,4-甲氧基-N,N-二甲基-2-(3-羰基-3-苯基-1-丙烯基)-,(E)- 苯磺酰氯化,4,5-二甲氧基-2-(3-羰基-3-苯基-1-丙烯基)-,(E)- 苯磺酰氯,4-甲氧基-3-(3-羰基-3-苯基-1-丙烯基)-,(E)- 苯甲醇,4-甲氧基-a-[2-(4-甲氧苯基)乙烯基]- 苯甲酸-[4-(3-氧代-3-苯基-丙烯基)-苯胺] 苯甲酸,3-[3-(4-溴苯基)-1-羰基-2-丙烯基]-4-羟基- 苯甲酰(2-羟基苯酰)甲烷 苯甲腈,4-(1-羟基-3-羰基-3-苯基丙基)- 苯基[2-(1-萘基)乙烯基]甲酮 苯基-(三苯基-丙-2-炔基)-醚 苯基-(2-苯基-2,3-二氢-苯并噻唑-2-基)-甲酮 苯亚甲基苯乙酮 苯乙酰腈,a-(1-氨基-2-苯基亚乙基)- 苯丙酸,a-苯甲酰-b-羰基-,苯基(苯基亚甲基)酰肼 苯,1-(2,2-二甲基-3-苯基丙基)-2-甲基- 苏木查耳酮 苄桂哌酯 苄基(4-氯-2-(3-氧代-1,3-二苯基丙基)苯基)氨基甲酸酯 芦荟提取物 腈苯唑 胀果甘草宁C 聚磷酸根皮酚